Corcept Therapeutics (CORT) Fair Value & DCF
Score
Corcept Therapeutics Incorporated (CORT) trades at $72.94 on $7.98B of equity value, with a trailing P/E of 49.27. Fair value on Stocklytics blends discounted cash flow and an earnings-based cross-check when the saved model is on file. The price and ratio here are from the live quote.